Journal Information
Most often read
2432
Chronic pancreatitis for the clinician. Part 2: Treatment and follow-up. Interdisciplinary position paper of the Societat Catalana de Digestologia and the Societat Catalana de PàncreesXavier Molero, Juan Ramon Ayuso, Joaquim Balsells, Jaume Boadas, Juli Busquets, Anna Casteràs, Mar Concepción, Míriam Cuatrecasas, ... Eva Cristina Vaquero
Gastroenterol Hepatol. 2022;45:304-14
2432
Open Article
1736
Position Statement. Recommendations of the Spanish Group on Crohn’s Disease and Ulcerative Colitis (GETECCU) on the treatment of strictures in Crohn’s diseaseCarme Loras, Miriam Mañosa, Xavier Andújar, Vicente Sánchiz, Marc Martí-Gallostra, Yamile Zabana, Ana Gutiérrez, Manuel Barreiro-de Acosta
Gastroenterol Hepatol. 2022;45:315-34
1736
Open access
Open Article
1507
Management of patients with Intestinal Bowel Disease and COVID-19: A review of current evidence and future perspectivesCarles Suria, Marta M. Bosca-Watts, Pablo Navarro, Joan Tosca, Rosario Anton, Ana Sanahuja, Marta Revaliente, Miguel Minguez
Gastroenterol Hepatol. 2022;45:383-9
1507
Open Article
1419
Relevance and needs of irritable bowel syndrome (IBS): Comparison with inflammatory bowel disease (IBD). (Please, if you are not interested in IBS, read it.)Fermín Mearin, Miquel Sans, Agustín Balboa
Gastroenterol Hepatol. 2022;45:789-98
1419
Open access
1361
Hepatitis B and C screening in hospitalized patients with SARS-CoV-2 infectionJudith Gómez Camarero, Ester Badia Aranda, Raisa Quiñones Castro, Rosa María Saiz Chumillas, Laura Alcoba Vega, Sandra Díez Ruiz, Noemí Gómez Manero, Raquel Vinuesa Campo, Francisco Jorquera Plaza
Gastroenterol Hepatol. 2022;45:256-64
1361
Open Article
1338
NSAIDs, gastrointestinal toxicity and inflammatory bowel diseaseGonzalo Hijos-Mallada, Carlos Sostres, Fernando Gomollón
Gastroenterol Hepatol. 2022;45:215-22
1338
Open Article
1108
Impact of the lockdown period due to the COVID-19 pandemic in patients with inflammatory bowel diseaseEngy Refaie, Sandra García Mateo, Samuel Jesús Martínez Domínguez, Carla Jerusalén Gargallo-Puyuelo, Laura Lario Quilez, Patricia Carrera-Lasfuentes, María Teresa Arroyo Villarino, Fernando Gomollón García
Gastroenterol Hepatol. 2022;45:114-22
1108
Open Article
1060
Self-medication with analgesics reported by patients with ulcerative colitis: An anonymous surveyIago Rodríguez-Lago, Francisco Mesonero, Gonzalo Hijos-Mallada, Mercedes Cañas, Roberto Saldaña, Claudia Savini, Sabela Fernández, Berta Juliá, ... on behalf of ACCU, GETECCU, GETEII
Gastroenterol Hepatol. 2022;45:457-63
1060
Open access
Open Article
986
Chronic pancreatitis for the clinician. Part 1: Etiology and diagnosis. Interdisciplinary position paper of the Societat Catalana de Digestologia and the Societat Catalana de PàncreesXavier Molero, Juan Ramon Ayuso, Joaquim Balsells, Jaume Boadas, Juli Busquets, Anna Casteràs, Mar Concepción, Míriam Cuatrecasas, ... Eva Cristina Vaquero
Gastroenterol Hepatol. 2022;45:231-48
986
Open Article
924
Pancreatic space occupying lesion (SOL): Another case of pancreatic adenocarcinoma?Raúl Velamazan, Sandra García, María Hernandez, Nuria Saura, Gonzalo Hijos, Daniel Abad, Samuel Martinez, Cristina Borao, ... Guillermo Garcia-Rayado
Gastroenterol Hepatol. 2022;45:207-8
924
Open Article
817
Recommendations of the Spanish Group on Crohn’s Disease and Ulcerative Colitis on the importance, screening and vaccination in inflammatory bowel disease patientsRocío Ferreiro-Iglesias, Marta Piqueras, Elena Ricart, Laura Sempere, Mariona Roca, Javier Martín de Carpi, Olga Benítez, Yamile Zabana, ... on behalf of GETECCU
Gastroenterol Hepatol. 2022;45:805-18
817
Open access
Open Article
783
Irritable bowel syndrome in inflammatory bowel disease. Synergy in alterations of the gut-brain axis?Edith Pérez de Arce, Rodrigo Quera, Caroll J. Beltrán, Ana María Madrid, Pilar Nos
Gastroenterol Hepatol. 2022;45:66-76
783
Open Article
748
Rumination syndrome: Critical reviewLuis Gerardo Alcala-Gonzalez, Xavier Serra, Elizabeth Barba
Gastroenterol Hepatol. 2022;45:155-63
748
Open Article
747
Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)Rocío Gallego-Durán, Agustín Albillos, Javier Ampuero, María Arechederra, Rafael Bañares, Ana Blas-García, Genoveva Berná, Esther Caparrós, ... Jordi Gracia-Sancho
Gastroenterol Hepatol. 2022;45:724-34
747
Open access
Open Article
646
V Spanish Consensus Conference on Helicobacter pylori infection treatmentJavier P. Gisbert, Javier Alcedo, Javier Amador, Luis Bujanda, Xavier Calvet, Manuel Castro-Fernández, Luis Fernández-Salazar, Emili Gené, ... Ignasi Puig
Gastroenterol Hepatol. 2022;45:392-417
646
Open Article
632
The EPAGE guidelines are not an effective strategy for managing colonoscopies during the COVID-19 pandemicLorena Rodríguez-Alonso, Francisco Rodríguez-Moranta, Sandra Maisterra, Josep M. Botargues, Ana Berrozpe, Alexandra Ruíz-Cerulla, Gerard Suris, Blau Camps, ... Jordi Guardiola
Gastroenterol Hepatol. 2022;45:9-17
632
Open Article
544
Evolution of the emotional impact in patients with early inflammatory bowel disease during and after Covid-19 lockdownLaura Sempere, Purificación Bernabeu, José Cameo, Ana Gutierrez, Raquel Laveda, Mariana Fe García, Mariam Aguas, Pedro Zapater, ... Carlos van-der Hofstadt
Gastroenterol Hepatol. 2022;45:123-33
544
Open Article
498
Achalasia and corkscrew oesophagus: An atypical presentation, a therapeutic challengeRubén Sánchez-Aldehuelo, Enrique Rodríguez de Santiago, Carlos Teruel Sánchez-Vegazo
Gastroenterol Hepatol. 2022;45:141-3
498
Open Article
453
Correlation between endoscopy and intestinal ultrasound for the evaluation of postoperative recurrence of Crohn’s diseaseJorge Yebra Carmona, Joaquín Poza Cordón, Cristina Suárez Ferrer, Eduardo Martín Arranz, Javier Lucas Ramos, Irene Andaluz García, María Sánchez Azofra, José Luis Rueda García, María Dolores Martín Arranz
Gastroenterol Hepatol. 2022;45:40-6
453
Open Article
351
Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA studyIgnacio Marín-Jiménez, Manuel Barreiro-de Acosta, María Esteve, Luisa Castro-Laria, Santiago García-López, Daniel Ceballos, Ana Echarri, María Dolores Martín-Arranz, ... for RAPIDA trial investigators
Gastroenterol Hepatol. 2022;45:165-76
351
Open Article